Nasal polyps—a model of chronic respiratory mucosal inflammation

This publication has 28 references indexed in Scilit:

• Expression of transforming growth factors-α and β messenger RNA and product by eosinophils in nasal polyps
  Journal of Allergy and Clinical Immunology, 1994
• Interleukin‐8 is a chemo‐attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects
  Clinical and Experimental Allergy, 1993
• The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis
  Clinical and Experimental Allergy, 1993
• Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease.
  The Journal of Experimental Medicine, 1992
• Locally applied GM-CSF induces the accumulation of α-smooth muscle act in containing myofibroblasts
  Virchows Archiv B Cell Pathology Including Molecular Pathology, 1991
• Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils.
  The Journal of Experimental Medicine, 1991
• Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophilsin vitro
  Clinical and Experimental Immunology, 1991
• The increased number of epithelial mast cells in nasal polyps and adjacent turbinates is not allergy‐dependent
  Allergy, 1990
• Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.
  Journal of Clinical Investigation, 1988
• Epithelial damage in nasal polyps
  Clinical and Experimental Allergy, 1984